NCT07757841 Real-World Effectiveness of Tezepelumab in Allergic Bronchopulmonary Aspergillosis Status NOT_YET_RECRUITING Phase NA
NCT07735494 Physical Activity Promotion and Clinical Remission in Severe Asthma Status RECRUITING Phase NA
NCT07721376 Multi-omics in Severe Asthma From Olive Pollen Allergy Status ACTIVE_NOT_RECRUITING Phase N/A
NCT07713498 Tapering of Inhaled Corticosteroids in Tezepelumab-treated Asthma patieNts: Impact on Clinical Outcomes Status ENROLLING_BY_INVITATION Phase N/A
NCT07532265 A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma Status RECRUITING Phase PHASE2
NCT07530770 Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis Status RECRUITING Phase N/A
NCT07363642 Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab Status RECRUITING Phase PHASE3
NCT07359846 A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2) Status RECRUITING Phase PHASE3
NCT07343661 Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA Status ENROLLING_BY_INVITATION Phase PHASE4
NCT07292805 Bronchial Thermoplasty for Adults With Severe Asthma in the Biologic Era Status RECRUITING Phase NA
NCT07276724 A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1) Status RECRUITING Phase PHASE3
NCT07218172 Characterization and Clinical Outcomes of Severe Asthma Patients in Israel Treated With Benralizumab (SAIL-B) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT07159295 Study in Portuguese Hospitals to Describe Patient Characteristics, Treatment Patterns and Outcomes Status COMPLETED Phase N/A
NCT07139899 Downstream Effects of Airway Mucus Plugs on 129Xenon MRI in Severe Asthma Status RECRUITING Phase N/A
NCT07013123 Potency of HDM Sublingual AIT Tablets in Assuring the Persistency of Asthma Control in HDM Allergic Patients With Severe Asthma, Treated With Tezepelumab Status NOT_YET_RECRUITING Phase PHASE3
NCT06998095 Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea Status NOT_YET_RECRUITING Phase N/A